UK markets closed
NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.20 +0.95 (+1.30%) GOLD FUTURES
2,375.70 +28.30 (+1.21%) DOW
38,799.37 +88.08 (+0.23%) Bitcoin GBP
55,449.19 +259.47 (+0.47%)
Vertex Pharmaceuticals Incorporated (VX1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 04:13PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 112.39B |
| Enterprise value | 103.73B |
| Trailing P/E | 30.64 |
| Forward P/E | 29.15 |
| PEG ratio (5-yr expected) | 0.63 |
| Price/sales (ttm) | 12.09 |
| Price/book (mrq) | 6.57 |
| Enterprise value/revenue | 11.11 |
| Enterprise value/EBITDA | 22.59 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.39 |
| 52-week change 3 | 40.33% |
| S&P500 52-week change 3 | 23.99% |
| 52-week high 3 | 439.45 |
| 52-week low 3 | 302.00 |
| 50-day moving average 3 | 388.48 |
| 200-day moving average 3 | 366.05 |
Share statistics
| Avg vol (3-month) 3 | 47 |
| Avg vol (10-day) 3 | 60 |
| Shares outstanding 5 | 258.05M |
| Implied shares outstanding 6 | 259.56M |
| Float 8 | 257.28M |
| % held by insiders 1 | 0.10% |
| % held by institutions 1 | 95.77% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 39.46% |
| Operating margin (ttm) | 45.20% |
Management effectiveness
| Return on assets (ttm) | 12.82% |
| Return on equity (ttm) | 24.38% |
Income statement
| Revenue (ttm) | 10.18B |
| Revenue per share (ttm) | 39.49 |
| Quarterly revenue growth (yoy) | 13.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 4.58B |
| Net income avi to common (ttm) | 4.02B |
| Diluted EPS (ttm) | 14.12 |
| Quarterly earnings growth (yoy) | 57.10% |
Balance sheet
| Total cash (mrq) | 10.17B |
| Total cash per share (mrq) | 39.42 |
| Total debt (mrq) | 721.3M |
| Total debt/equity (mrq) | 3.89% |
| Current ratio (mrq) | 3.50 |
| Book value per share (mrq) | 71.80 |
Cash flow statement
| Operating cash flow (ttm) | 3.94B |
| Levered free cash flow (ttm) | 3.31B |
© 2024 Yahoo. All rights reserved.